Enhanced Releases Clinical Trial Data Ahead of Inaugural Games
Event summary
- Enhanced's IRB-approved clinical trial data is now available on ClinicalTrials.gov under study acronym ASCEND001.
- 91% of athletes in the trial used testosterone or testosterone esters as part of individualized protocols.
- The inaugural Enhanced Games are scheduled for May 24, 2026, in Las Vegas.
- The trial's interventional phase has concluded, beginning a five-year observational monitoring period.
The big picture
Enhanced is positioning itself at the intersection of elite sports and performance medicine, aiming to revolutionize the category with IRB-approved research. The company's strategy hinges on translating high-performance protocols into consumer products, potentially disrupting traditional health and wellness markets. The inaugural Enhanced Games serve as both a proving ground for the company's medical program and a high-profile platform to showcase its approach to athlete optimization.
What we're watching
- Data Proprietary
- How Enhanced will leverage proprietary clinical data to build its competitive moat in the performance medicine category.
- Consumer Translation
- The pace at which learnings from elite athlete protocols will be integrated into Enhanced's consumer platform.
- Regulatory Scrutiny
- Whether the FDA and other health authorities will increase oversight of performance-enhancing substances used in the study.
Related topics